8-K: Lantheus Merger Faces FTC Scrutiny, Timeline Uncertain

Lantheus Holdings, Inc. announced that both the company and its merger partner received a Second Request from the FTC, extending the HSR Act waiting period and casting uncertainty on the previously anticipated first-half 2027 closing.

Summary

• Lantheus Holdings, Inc. reported on October 21, 2026, that it and its merger partner, Curium US Holdings LLC (Parent), received a Second Request for additional information from the Federal Trade Commission (FTC).
• This Second Request is in connection with the FTC's review of the proposed merger between Lantheus and Parent.
• The effect of the Second Request is to extend the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) until 30 days after both parties substantially comply with the requests, unless terminated earlier by the FTC.
• Lantheus and Parent expect to respond promptly and continue to cooperate with the FTC.
• Completion of the merger remains contingent on the HSR Act waiting period and other closing conditions.
• The parties still anticipate consummating the merger in the first half of 2027, but this is now subject to the FTC review process.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative development due to the FTC's Second Request, which introduces uncertainty and potential delays to the previously expected merger timeline.

Positives

• Lantheus and Parent are cooperating and expect to respond promptly to the FTC's Second Request.
• The parties continue to expect to consummate the merger in the first half of 2027, indicating continued commitment to the deal despite the delay.

Negatives

• The FTC has issued a Second Request for additional information, indicating a deeper review of the merger.
• The HSR Act waiting period is extended, creating uncertainty regarding the exact closing date of the merger.
• The merger's completion is now subject to the satisfactory resolution of the FTC's review and the satisfaction of other closing conditions.

Risks

• Uncertainty regarding the timing of the merger due to the FTC's extended review.
• Possibility that conditions to the merger, including the HSR Act waiting period, may not be satisfied or waived on the expected timetable.
• Risk of termination of the Merger Agreement.
• Uncertainty regarding the achievement of milestones for contingent value rights (CVRs) and potential payments to holders.
• Disruption from the merger transaction and its pendency impacting Lantheus's business, including supplier and partner responses.
• Diversion of management time and attention from ongoing business operations.
• Potential changes to Lantheus's business between the announcement and closing of the merger.
• The effects of the merger announcement on Lantheus's share price.

Future Outlook

The company and its merger partner continue to expect to consummate the merger in the first half of 2027, but this is now subject to the satisfactory resolution of the FTC's review and the expiration or termination of the HSR Act waiting period.

Management Comments

• The parties expect to promptly respond to the Second Requests and to continue to work cooperatively with the FTC in its review of the Merger.

Industry Context

StockSavvy.ai notes that increased scrutiny from regulatory bodies like the FTC on mergers and acquisitions is a growing trend across various industries, particularly in sectors undergoing consolidation. This filing highlights the potential for antitrust reviews to introduce significant delays and uncertainties into M&A timelines, impacting deal certainty and market perception.

Stakeholder Impact

• Shareholders: Potential impact on share price due to merger uncertainty and potential delays; continued expectation of merger completion in H1 2027 provides some stability.
• Employees: Potential disruption and diversion of management attention from ongoing business operations.
• Business Partners/Suppliers: May experience disruption or uncertainty due to the pendency of the merger.
• Creditors: Merger completion is subject to conditions, introducing a degree of uncertainty regarding the long-term structure of the combined entity.

Next Steps

• Respond promptly to the FTC's Second Requests.
• Continue to work cooperatively with the FTC.
• Satisfy other closing conditions specified in the Merger Agreement.
• Await expiration or termination of the HSR Act waiting period.

Key Dates

Recommendation

The filing introduces uncertainty regarding the timeline for the Lantheus merger due to an FTC Second Request. While the company expects to close in the first half of 2027, the regulatory review process could lead to delays or unforeseen conditions. Given this increased uncertainty and the potential for the deal to be scrutinized further, a 'hold' recommendation is prudent until more clarity emerges from the FTC review.

Keywords

Merger, Antitrust Review, FTC, HSR Act, Regulatory Approval, Lantheus Holdings, Curium US Holdings, Antitrust Improvements Act